Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform
BORDEAUX, France & MEMPHIS, Tenn., July 15, 2026--(BUSINESS WIRE)--Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The first milestone of this partnership focuses on preclinical research aimed at supporting the European regulatory approval of a surgeon-assisted robotic system for spine surgery. This collaboration brings together the clinical, academic and research expertise of Amiens-Picardie University Hospital, leveraging its hospital-university teams specializing in robotic surgery within SimUSanté®, together with the industrial expertise of IMPLANET and 8i Robotics, to evaluate the potential benefits of a multi-arm surgical robot in the planning and execution of spine surgery procedures.
Ludovic Lastennet, Chief Executive Officer of IMPLANET, stated: "As part of our strategic plan, this tripartite partnership between IMPLANET, 8i Robotics and Amiens-Picardie University Hospital positions IMPLANET at the forefront of the clinical evaluation of a robotic solution that is unique in the world. The technologies developed by 8i Robotics represent the next generation of surgeon-supervised surgical assistance, enabling more efficient robotic procedures while enhancing patient safety. This clinical partnership will initially enable us to rapidly establish additional clinical research collaborations with leading French hospitals, with the objective of completing the regulatory approval process for robotic implant solutions in the European market."
"The installation of the 8i robot represents a significant opportunity for our research and training teams. Through this partnership with IMPLANET and 8i Robotics, we intend to further evaluate innovative technological solutions that have the potential to enhance spine surgery practices," stated Dr. François Deroussen.
This installation represents the first milestone of the clinical and regulatory partnership between IMPLANET and 8i Robotics. It will support research programs with leading French hospitals and prepare the CE marking of a robotic solution that is unique in Europe. It is fully aligned with IMPLANET's long-term strategy to integrate the latest advances and innovations in spine surgery (including deformity correction systems, minimally invasive product lines, robotics and artificial intelligence) into its commercial offering.